The clinical guideline outlines the use of Carbetocin to prevent postpartum haemorrhage in caesarean births. It recommends Carbetocin for all patients undergoing caesarean birth unless contraindicated. The document details responsibilities of the healthcare team and provides instructions on administration, dosage, and contraindications. It emphasizes that Carbetocin should only be given after the birth of the baby and as soon as possible after umbilical cord clamping. The guideline also highlights potential risks and cautions for use, such as cardiovascular disease and hyponatraemia. Monitoring and review of compliance with guidelines are deemed necessary.